- Home
- FEMY vs AACG Comparison
FEMY vs AACG Comparison
Compare FEMY & AACG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- AACG
- Stock Information
- Founded
- FEMY 2004
- AACG 1999
- Country
- FEMY United States
- AACG China
- Employees
- FEMY 71
- AACG N/A
- Industry
- FEMY Medical/Dental Instruments
- AACG Other Consumer Services
- Sector
- FEMY Health Care
- AACG Real Estate
- Exchange
- FEMY Nasdaq
- AACG Nasdaq
- Market Cap
- FEMY 23.1M
- AACG 24.4M
- IPO Year
- FEMY 2021
- AACG N/A
- Fundamental
- Price
- FEMY $0.71
- AACG $1.96
- Analyst Decision
- FEMY Strong Buy
- AACG
- Analyst Count
- FEMY 3
- AACG 0
- Target Price
- FEMY $7.33
- AACG N/A
- AVG Volume (30 Days)
- FEMY 238.0K
- AACG 690.5K
- Earning Date
- FEMY 08-08-2025
- AACG 08-06-2025
- Dividend Yield
- FEMY N/A
- AACG N/A
- EPS Growth
- FEMY N/A
- AACG N/A
- EPS
- FEMY N/A
- AACG N/A
- Revenue
- FEMY $1,887,016.00
- AACG $39,064,701.00
- Revenue This Year
- FEMY $283.83
- AACG N/A
- Revenue Next Year
- FEMY $161.03
- AACG N/A
- P/E Ratio
- FEMY N/A
- AACG N/A
- Revenue Growth
- FEMY 98.61
- AACG 15.19
- 52 Week Low
- FEMY $0.69
- AACG $0.50
- 52 Week High
- FEMY $1.80
- AACG $2.30
- Technical
- Relative Strength Index (RSI)
- FEMY 34.99
- AACG 60.72
- Support Level
- FEMY $0.72
- AACG $1.42
- Resistance Level
- FEMY $1.00
- AACG $2.13
- Average True Range (ATR)
- FEMY 0.06
- AACG 0.38
- MACD
- FEMY -0.01
- AACG 0.04
- Stochastic Oscillator
- FEMY 0.89
- AACG 72.58
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.